temozolomide,talazoparib
pfizer
['talazo', 'temozolomide']
abstract 6186: patient-derived tumor organoids with p53 mutations, and not wild-type p53, demonstrate synergistic sensitivity to treatment with temozolomide in combination with talazoparib parp inhibitor please visit our poster at #aacr23
Cancer Researcher, Educator, Choreographer, and Scholar. Research specializing in mutant p53, MDM2, and MDMX. Teaching Choreographing Genomics and Cell Biology.